Long-term results of myocardial revascularization in patients with multivessel disease

Insights

Coronary artery bypass grafting (CABG) is superior to percutaneous coronary intervention (PCI) with drug-eluting stents for intermediate SYNTAX scores, showing fewer repeat revascularizations over 9 years.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Surgery

Background:

  • The optimal revascularization strategy for multivessel coronary artery disease remains a subject of debate.
  • Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are the primary treatment options.
  • Drug-eluting stents (DES) have improved PCI outcomes, but comparisons with CABG persist.

Purpose of the Study:

  • To compare the long-term efficacy and safety of CABG versus PCI with DES in patients with multivessel disease.
  • To evaluate outcomes based on SYNTAX score (SS) stratification.
  • To assess major adverse cardiac and cerebrovascular events (MACCE), repeat revascularization (RR), left ventricular ejection fraction (LVEF), and SYNTAX score changes.

Main Methods:

  • A prospective study included 406 patients with multivessel disease undergoing either PCI with DES (n=200) or CABG (n=206).
  • Patients were stratified by SYNTAX score (SS ≤ 22 or SS 23-32).
  • Follow-up averaged 9±1.9 years, monitoring MACCE, RR, LVEF, and SS dynamics.

Main Results:

  • Patients with intermediate SS (23-32) required significantly more RR after PCI than CABG (64% vs 22.6%).
  • No significant differences in overall MACCE were observed between PCI and CABG groups.
  • A greater decrease in LVEF was noted in the low SS subgroup after CABG compared to PCI (39.5% vs 27.7%).

Conclusions:

  • CABG demonstrated an advantage over PCI with DES in intermediate SS patients regarding MACCE, primarily due to a lower RR rate.
  • The CABG group experienced more significant atherosclerosis progression and a higher incidence of heart failure.
  • Long-term data suggests CABG may be preferable for certain patient subsets with multivessel disease.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20